FSL0756
- Structure
- InChI=1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
- InChIKey=SWIJYDAEGSIQPZ-UHFFFAOYSA-N
- Synonyms
-
- 1508-65-2
- Oxybutynin chloride
- Origin
- Chemically synthesized
- Biological activities
- Anticholinergic activity
- Therapeutic
-
Antispasmodic
- Target
-
Muscarinic acetylcholine receptor
- Assay information
-
Muscarinic acetylcholine receptor binding (Ki [nM]): M1 (1.0-6.1), M2 (8.1-21), M3 (0.78-3.4), M4 (6.6), M5 (18)
- References
-
-
Sonda S, Katayama K, Fujio M, Sakashita H, Inaba K, Asano K, Akira T
1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.
Bioorg Med Chem Lett, 17(4): 925-931 (2007) 17188867 doi: 10.1016/j.bmcl.2006.11.058
-
Ohtake A, Saitoh C, Yuyama H, Ukai M, Okutsu H, Noguchi Y, Hatanaka T, Suzuki M, Sato S, Sasamata M, Miyata K
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Biol Pharm Bull, 30(1): 54-58 (2007) 17202659
-
ROSSMAN ME, MERLIS S
A CLINICAL EVALUATION OF OXYBUTYNIN CHLORIDE IN THE TREATMENT OF GASTROINTESTINAL DISEASE.
Curr Ther Res Clin Exp, 6: 284-289 (1964) 14173506